|
LIG4 expression based on
|
KIRP : Kidney renal papillary cell carcinoma
| Comparison | Statistical significance |
| Normal-vs-Primary | 6.48439999999528E-05 |
|
KIRP : Kidney renal papillary cell carcinoma Note
Cancer stage information is not available for 89 samples.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Stage1 |
5.83690000000026E-05 |
| Normal-vs-Stage2 |
3.309000E-01 |
| Normal-vs-Stage3 |
3.72539999999866E-05 |
| Normal-vs-Stage4 |
1.113800E-01 |
| Stage1-vs-Stage2 |
4.568400E-01 |
| Stage1-vs-Stage3 |
6.766500E-02 |
| Stage1-vs-Stage4 |
7.061600E-01 |
| Stage2-vs-Stage3 |
1.120240E-01 |
| Stage2-vs-Stage4 |
4.961800E-01 |
| Stage3-vs-Stage4 |
5.274600E-01 |
|
|
KIRP : Kidney renal papillary cell carcinoma Note
Patient race information is not available for 15 samples and two samples from American Indians not included in the above plot.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Caucasian |
9.86469999999517E-05 |
| Normal-vs-AfricanAmerican |
1.596060E-03 |
| Normal-vs-Asian |
3.7066000047048E-08 |
| Caucasian-vs-AfricanAmerican |
8.188400E-01 |
| Caucasian-vs-Asian |
8.039800E-04 |
| AfricanAmerican-vs-Asian |
2.164400E-02 |
|
|
KIRP : Kidney renal papillary cell carcinoma
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Male |
1.038590E-04 |
| Normal-vs-Female |
1.202500E-03 |
| Male-vs-Female |
8.079000E-01 |
|
|
KIRP : Kidney renal papillary cell carcinoma Note
Patient BMI information is not available for 72 samples.
| Descriptions |
| Normal weight |
BMI greater than equal to 18.5 and BMI less than 25 |
Extereme weight |
BMI greater than equal to 25 and BMI less than 30 |
| Obese |
BMI greater than equal to 30 and BMI less than 40 |
Extreme Obese |
BMI greater than 40 |
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Normal_Weight |
9.791900E-04 |
| Normal-vs-Extreme_Weight |
1.7113899999921E-05 |
| Normal-vs-Obese |
6.341900E-03 |
| Normal-vs-Extreme_Obese |
1.676200E-01 |
| Normal_Weight-vs-Extreme_Weight |
8.170200E-01 |
| Normal_Weight-vs-Obese |
5.005200E-01 |
| Normal_Weight-vs-Extreme_Obese |
3.968800E-01 |
| Extreme_Weight-vs-Obese |
2.879800E-01 |
| Extreme_Weight-vs-Extreme_Obese |
2.519200E-01 |
| Obese-vs-Extreme_Obese |
6.855800E-01 |
|
|
KIRP : Kidney renal papillary cell carcinoma Note
Patient age information is not available for 3 samples.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Age(21-40Yrs) |
8.26160000000353E-05 |
| Normal-vs-Age(41-60Yrs) |
6.879000E-03 |
| Normal-vs-Age(61-80Yrs) |
7.50750000000355E-05 |
| Normal-vs-Age(81-100Yrs) |
7.56450000000131E-05 |
| Age(21-40Yrs)-vs-Age(41-60Yrs) |
8.932300E-02 |
| Age(21-40Yrs)-vs-Age(61-80Yrs) |
2.301200E-01 |
| Age(21-40Yrs)-vs-Age(81-100Yrs) |
5.062400E-01 |
| Age(41-60Yrs)-vs-Age(61-80Yrs) |
1.061440E-01 |
| Age(41-60Yrs)-vs-Age(81-100Yrs) |
3.126200E-02 |
| Age(61-80Yrs)-vs-Age(81-100Yrs) |
1.871230E-01 |
|
|
KIRP : Kidney renal papillary cell carcinoma NOTE
Histology information is not available for 17 samples.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-VS-Type1 PRCC |
9.302000E-03 |
| Normal-VS-Type2 PRCC |
1.24869999995614E-06 |
| Normal-VS-KIRP CIMP |
1.36369999736985E-08 |
| Normal-VS-Unclassified PRCC |
3.405600E-02 |
| Type1 PRCC-VS-Type2 PRCC |
1.095410E-03 |
| Type1 PRCC-VS-KIRP CIMP |
1.0047999998708E-07 |
| Type1 PRCC-VS-Unclassified PRCC |
6.362600E-01 |
| Type2 PRCC-VS-KIRP CIMP |
9.020200E-04 |
| Type2 PRCC-VS-Unclassified PRCC |
7.634300E-02 |
| KIRP CIMP-VS-Unclassified PRCC |
2.40099999999632E-05 |
|
Histologic PRCC subtypes: Ricketts CJ et al, The Cancer Genome Atlas Comprehensive Molecular Characterization of Renal Cell Carcinoma. Cell Rep. 2018 Apr 3;23(1):313-326.e5. doi: 10.1016/j.celrep.2018.03.075
|
KIRP : Kidney renal papillary cell carcinoma Note
Nodal metastais status is not available for 1 sample and cancer in nearby lymph nodes cannot be measured (NX) in 211 samples.
| pathologic_N descriptions |
| N0 | No regional lymph node metastasis |
N1 | Metastases in 1 to 3 axillary lymph nodes |
| N2 | Metastases in 4 to 9 axillary lymph nodes |
N3 | Metastases in 10 or more axillary lymph nodes |
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-N0 |
4.35600000003866E-06 |
| Normal-vs-N1 |
4.118500E-03 |
| Normal-vs-N2 |
2.44415598871228E-12 |
| N0-vs-N1 |
8.235400E-01 |
| N0-vs-N2 |
2.15779999979127E-07 |
| N1-vs-N2 |
8.182700E-03 |
|
|
